Genitalia, Female
Conditions
Interventions
This is a prospective, non-randomized, single-arm clinical study, designed as a pilot project, involving 13 breast cancer survivors, all diagnosed with genitourinary syndrome of menopause (GSM). The s
Sponsors
Centro de Pós-Graduação da Ciências Médicas de Minas Gerais – Faculdade de Ciências Médicas
Centro de Pós-Graduação da Ciências Médicas de Minas Gerais – Faculdade de Ciências Médicas
Eligibility
Sex/Gender
Female
Age
30 Years to 70 Years
Inclusion criteria
Inclusion criteria: Women patient aged between 30 and 70 years.History of hormone-dependent breast cancer and use of hormone blockers. End of chemotherapy treatment.Patients who give their informed consent to take part in the study.Patients with at least 3 symptoms of genitourinary menopausal syndrome (GMS)
Exclusion criteria
Exclusion criteria: Patients who do not wish to have their data used in the study.Patients who refuse to undergo biopsy and cytological examination before or after treatment.Patients under 30 and over 70.Patients undergoing chemotherapy.Pregnant and breastfeeding women.Patients who do not have at least 3 symptoms of genitourinary menopausal syndrome (GMS).Patients who have already undergone previous vaginal laser treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome: at the end of the study, a vaginal health index of more than 15 and a score on the symptom intensity questionnaire of less than 10 are expected, reflecting a normal vaginal mucosa | — |
Secondary
| Measure | Time frame |
|---|---|
| With the improvement in vaginal health, it is expected that there will be an improvement in sexual health as assessed by the FSFI and patient satisfaction with the treatment as assessed by the likert scale | — |
Countries
Brazil
Contacts
Public ContactKeila Ferreira
Keila Seabra Dermatology Clinic
Outcome results
None listed